Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 24(2)2023 Jan 04.
Article in English | MEDLINE | ID: mdl-36674504

ABSTRACT

Lung cancer has the highest mortality among all types of cancer; during its development, cells can acquire neural and endocrine properties that affect tumor progression by releasing several factors, some acting as immunomodulators. Neuroendocrine phenotype correlates with invasiveness, metastasis, and low survival rates. This work evaluated the effect of neuroendocrine differentiation of adenocarcinoma on the mouse immune system. A549 cells were treated with FSK (forskolin) and IBMX (3-Isobutyl-1-methylxanthine) for 96 h to induce neuroendocrine differentiation (NED). Systemic effects were assessed by determining changes in circulating cytokines and immune cells of BALB/c mice immunized with PBS, undifferentiated A549 cells, or neuroendocrine A549NED cells. A549 cells increased circulating monocytes, while CD4+CD8- and CD4+CD8+ T cells increased in mice immunized with neuroendocrine cells. IL-2 and IL-10 increased in mice that received untreated A549 cells, suggesting that the immune system mounts a regulated response against adenocarcinoma, which did not occur with A549NED cells. Cocultures demonstrated the cytotoxic capacity of PBMCs when confronted with A549 cells, while in the presence of neuroendocrine cells they not only were unable to show cytolytic activity, but also lost viability. Neuroendocrine differentiation seems to mount less of an immune response when injected in mice, which may contribute to the poor prognosis of cancer patients affected by this pathology.


Subject(s)
Adenocarcinoma , Antineoplastic Agents , Lung Neoplasms , Mice , Animals , CD8-Positive T-Lymphocytes , Lung Neoplasms/pathology , Adenocarcinoma/pathology , Immunity , Cell Differentiation
2.
Int J Mol Sci ; 21(4)2020 Feb 20.
Article in English | MEDLINE | ID: mdl-32093298

ABSTRACT

It is known that growth hormone (GH) is expressed in immune cells, where it exerts immunomodulatory effects. However, the mechanisms of expression and release of GH in the immune system remain unclear. We analyzed the effect of growth hormone-releasing hormone (GHRH), thyrotropin-releasing hormone (TRH), ghrelin (GHRL), and somatostatin (SST) upon GH mRNA expression, intracellular and released GH, Ser133-phosphorylation of CREB (pCREBS133), intracellular Ca2+ levels, as well as B-cell activating factor (BAFF) mRNA expression in bursal B-lymphocytes (BBLs) cell cultures since several GH secretagogues, as well as their corresponding receptors (-R), are expressed in B-lymphocytes of several species. The expression of TRH/TRH-R, ghrelin/GHS-R1a, and SST/SST-Rs (Subtypes 1 to 5) was observed in BBLs by RT-PCR and immunocytochemistry (ICC), whereas GHRH/GHRH-R were absent in these cells. We found that TRH treatment significantly increased local GH mRNA expression and CREB phosphorylation. Conversely, SST decreased GH mRNA expression. Additionally, when added together, SST prevented TRH-induced GH mRNA expression, but no changes were observed in pCREBS133 levels. Furthermore, TRH stimulated GH release to the culture media, while SST increased the intracellular content of this hormone. Interestingly, SST inhibited TRH-induced GH release in a dose-dependent manner. The coaddition of TRH and SST decreased the intracellular content of GH. After 10 min. of incubation with either TRH or SST, the intracellular calcium levels significantly decreased, but they were increased at 60 min. However, the combined treatment with both peptides maintained the Ca2+ levels reduced up to 60-min. of incubation. On the other hand, BAFF cytokine mRNA expression was significantly increased by TRH administration. Altogether, our results suggest that TRH and SST are implicated in the regulation of GH expression and release in BBL cultures, which also involve changes in pCREBS133 and intracellular Ca2+ concentration. It is likely that TRH, SST, and GH exert autocrine/paracrine immunomodulatory actions and participate in the maturation of chicken BBLs.


Subject(s)
Avian Proteins/immunology , B-Lymphocytes/immunology , Bursa of Fabricius/immunology , Chickens/immunology , Ghrelin/immunology , Growth Hormone-Releasing Hormone/immunology , Growth Hormone/immunology , Somatostatin/immunology , Thyrotropin-Releasing Hormone/immunology , Animals , B-Lymphocytes/cytology , Bursa of Fabricius/cytology , Cell Culture Techniques , Cells, Cultured
3.
J Alzheimers Dis ; 55(3): 1273-1283, 2017.
Article in English | MEDLINE | ID: mdl-27792010

ABSTRACT

Dementia caused by Alzheimer's disease (AD) is mainly characterized by accumulation in the brain of extra- and intraneuronal amyloid-ß (Aß) and tau proteins, respectively, which selectively affect specific regions, particularly the neocortex and the hippocampus. Sporadic AD is mainly caused by an increase in apolipoprotein E, a component of chylomicrons, which are cholesterol transporters in the brain. Recent studies have shown that high lipid levels, especially cholesterol, are linked to AD. Adenosine is an atypical neurotransmitter that regulates a wide range of physiological functions by activating four P1 receptors (A1, A2A, A2B, and A3) and P2 purinergic receptors that are G protein-coupled. A1 receptors are involved in the inhibition of neurotransmitter release, which could be related to AD. The aim of the present work was to study the effects of a lard-enriched diet (LED) on cognitive and memory processes in adult rats (6 months of age) as well as the effect of theobromine on these processes. The results indicated that the fat-enriched diet resulted in a long-term deterioration in cognitive and memory functions. Increased levels of Aß protein and IL-1ß were also observed in the rats fed with a high-cholesterol diet, which were used to validate the AD animal model. In addition, the results of qPCR and immunohistochemistry indicated a decrease in gene expression and distribution of A1 purinegic receptor, respectively, in the hippocampus of LED-fed rats. Interestingly, theobromine, at both concentrations tested, restored A1 receptor levels and improved cognitive functions and Aß levels for a dose of 30 mg/L drinking water.


Subject(s)
Alzheimer Disease/pathology , Brain/drug effects , Gene Expression Regulation/drug effects , Receptors, Purinergic P1/metabolism , Theobromine/administration & dosage , Vasodilator Agents/administration & dosage , Alzheimer Disease/etiology , Amyloid beta-Peptides/metabolism , Analysis of Variance , Animals , Brain/metabolism , Cholesterol/blood , Diet, High-Fat/adverse effects , Disease Models, Animal , Gene Expression Regulation/physiology , Interleukin-1beta/metabolism , Male , Maze Learning/drug effects , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptor, Adenosine A1/genetics , Receptor, Adenosine A1/metabolism , Receptors, Purinergic P1/genetics , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2/metabolism , Recognition, Psychology/drug effects
4.
Gene Expr Patterns ; 21(2): 81-8, 2016 07.
Article in English | MEDLINE | ID: mdl-27545450

ABSTRACT

Gene coding for ATP-gated receptor ion channels (P2X1-7) has been associated with the developmental process in various tissues; among these ion channel subtypes, P2X6 acts as a physiological regulator of P2X4 receptor functions when the two receptors form heteroreceptors. The P2X4 receptor is involved in pain sensation, the inflammatory process, and body homeostasis by means of Mg(2+) absorption through the intestine. The small intestine is responsible for the absorption and digestion of nutrients; throughout its development, several gene expressions are induced that are related to nutrients received, metabolism, and other intestine functions. Previous work has shown a differential P2X4 and P2X6 protein distribution in the small intestine of newborn and adult rats; however, it is not well-known at what age the change in the relationship between the gene and protein expression occurs and whether or not these receptors are colocalized. In this work, we evaluate P2X4 and P2X6 gene expression patterns by qPCR from embryonic (E18, P0, P7, P17, P30) to adult age in rat gut, as well as P2X6/P2X4 colocalization using qRT-PCR and confocal immunofluorescence in proximal and distal small intestine sections. The results showed that P2X6 and P2X4 gene expression levels of both receptors decreased at the embryonic-perinatal transition, whereas from ages P17 to P30 (suckling-weaning transition) both receptors increased their gene expression levels. Furthermore, P2X4 and P2X6 proteins were expressed in a different way during rat small intestine development, showing a higher colocalization coefficient at age P30 in both intestine regions. Those results suggest that purinergic receptors may play a role in intestinal maturation, which is associated with age and intestinal region.


Subject(s)
Embryonic Development/genetics , Intestine, Small/growth & development , Receptors, Purinergic P2X4/genetics , Receptors, Purinergic P2/genetics , Adenosine Triphosphate/genetics , Adenosine Triphosphate/metabolism , Animals , Digestion/genetics , Gene Expression Regulation, Developmental , Intestine, Small/metabolism , Rats , Receptors, Purinergic P2/biosynthesis , Receptors, Purinergic P2X4/biosynthesis
5.
J Med Food ; 19(10): 970-977, 2016 Oct.
Article in English | MEDLINE | ID: mdl-30913400

ABSTRACT

Aerial parts of Medicago sativa L. have been used as food and its consumption has been associated with health benefits, one among the most important being menopausal symptoms control. This work was aimed to explore possible pharmacological effects of two new alfalfa-derived products that have recently emerged as daily beverage preparations. In exploring their potential estrogenic effects, they produced no relevant alteration in the uterus. However, lowering glucose levels until normal values without causing further hypoglycemic effect were observed, when rats were treated with 1.5 g/kg/day samples. In vivo acute toxicity was not found when the alfalfa products were tested up to 3 g/kg rat weight. Furthermore, in vitro studies were conducted to assess their possible toxic effects. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase tests were carried out on the Caco-2 cell model to determine cell viability and membrane integrity. A concentration-dependent effect was observed, with a significant decrease in cell viability after exposure to concentrations of alfalfa product up to 100 mg/mL (after 3 h of incubation) and 50 mg/mL (after 24 h of treatment). Although in vitro level, the decrease in cell viability at these still low doses may underlie some toxicity, making necessary additional studies before any recommendation of a sustained consumption of these products by humans.

6.
Int J Dev Neurosci ; 42: 80-5, 2015 May.
Article in English | MEDLINE | ID: mdl-25720309

ABSTRACT

Food intake regulation is a complex mechanism that involves endogenous substances and central nervous system structures like hypothalamus or even hippocampus. The neurotransmitter serotonin is distinguished as food intake mediator; within its multiples receptors, the 5-HT2C type is characterized by its inhibitory appetite action but there is no information about 5-HT5A receptors involvement in obesity disease. It is also unknown if there are any changes in the receptors expression in rats hippocampus with induced obesity during development through a high energy diet (HED) supplemented with tryptophan (W). To appreciate the receptors expression pattern in the hippocampus, obesity was induced to young Sprague Dawley rats through a HED and supplemented with W. Immunocytochemical and western blot techniques were used to study the receptor distribution and quantify the protein expression. The rats with HED diet developed obesity until week 13 of treatment. The 5-HT2C receptor expression decreased in CA1, CA2, CA3 and DG of HED group; and also in CA2, CA3 and DG for HEDW group. The 5-HT5A receptor expression only decreased in DG for HED group. Variations of the two serotonin receptors subtypes support their potential role in obesity.


Subject(s)
Dietary Supplements/adverse effects , Hippocampus/metabolism , Obesity/chemically induced , Receptor, Serotonin, 5-HT2C/metabolism , Receptors, Serotonin/metabolism , Tryptophan/adverse effects , Analysis of Variance , Animals , Body Weight/physiology , Disease Models, Animal , Drinking , Eating , Gene Expression Regulation , Male , Obesity/pathology , Rats , Rats, Sprague-Dawley , Time Factors
7.
Neurochem Int ; 73: 166-71, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24333324

ABSTRACT

Solute neutral amino acid transporter 5 (SNAT5/SN2) is a member of the System N family, expressed in glial cells in the adult brain, able to transport glutamine, histidine or glycine among other substrates. Its tight association with synapses and its electroneutral mode of operation that allows the bidirectional movement of substrates, supports the idea that this transporter participates in the function of the glutamine-glutamate cycle between neurons and glia. Moreover, SNAT5/SN2 might contribute to the regulation of glycine concentration in glutamatergic synapses and, therefore, to the functioning of the N-methyl-d-aspartate (NMDA) subtype of glutamate receptors. Ontogenic maturation of these synapses occurs postnatally through the coordinate expression of a large number of receptors, transporters, structural and regulatory proteins that ensure the correct operation of the excitatory pathways in the central nervous system. Since the temporal pattern of expression of SNAT5/SN2 is unknown, we analyzed it by immunoblot and immunohistochemical techniques. Results indicate that the expression of SNAT5/SN2 is triggered between the second and third postnatal week in the cerebral cortex, in parallel to the expression of the vesicular glutamate transporter vGLUT1 and the glial glutamate transporter GLT1/EAAT2. In the cerebellum, this process occurs about one week later than in the cerebral cortex. Immunohistochemical staining of cortical sections shows that from postnatal day 14 to adulthood the transporter was expressed exclusively in glial cells. Our results are consistent with the idea that SNAT5/SN2 expression is coordinated with that of other proteins necessary for the operation of glutamatergic synapses and reinforce the existence of a regulatory cross-talk between neurons and glia that orchestrates the building up of these synapses.


Subject(s)
Amino Acid Transport Systems, Neutral/genetics , Amino Acid Transport Systems, Neutral/physiology , Glutamic Acid/physiology , Synaptic Transmission/physiology , Amino Acid Transport System X-AG/metabolism , Animals , Excitatory Amino Acid Transporter 2/biosynthesis , Excitatory Amino Acid Transporter 2/genetics , Female , Glucose Transporter Type 1/biosynthesis , Glucose Transporter Type 1/genetics , Male , Neuroglia/physiology , Pregnancy , Rats , Rats, Wistar , Synaptic Transmission/genetics
8.
Neurosci Lett ; 509(2): 92-5, 2012 Feb 16.
Article in English | MEDLINE | ID: mdl-22230887

ABSTRACT

The purinergic receptors P2X(4) and P2X(6) are ion channels activated by ATP. These receptors are present in the gastrointestinal tract, and they are involved in synaptic transmission, taste sensation, and pain, among other functions. In this work, we studied the distribution of P2X(4) and P2X(6) receptors in proximal and distal regions of the gut newborn and adult rats. Using immunohistochemistry, purinergic receptors were found in gut epithelial cells and capillary vessels. In both proximal and distal regions of newborn rats, we observed P2X(4) signal in epithelial cells, whereas P2X(6) was present in capillary vessels in the proximal region and to a lesser extent in the distal region. In both regions of adult gut, we observed P2X(4) and P2X(6) immunostain in the capillary vessels. Semi-quantification indicated a significant difference in the amount of P2X(4) between proximal regions, whereas the P2X(6) content of both newborn regions differed from that in adult proximal gut. We conclude that P2X(4) and P2X(6) purinoreceptors are present in the gut from birth and that they are differentially distributed among regions.


Subject(s)
Aging/metabolism , Gastrointestinal Tract/growth & development , Gastrointestinal Tract/metabolism , Receptors, Purinergic P2X4/metabolism , Receptors, Purinergic P2/metabolism , Animals , Animals, Newborn , Gastrointestinal Tract/blood supply , Organ Specificity , Rats , Rats, Sprague-Dawley
9.
Int J Dev Neurosci ; 29(7): 743-8, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21718781

ABSTRACT

The sodium-coupled neutral amino acid transporter 2 (SNAT2) is a protein that is expressed ubiquitously in mammalian tissues and that displays Na(+), voltage and pH dependent activity. This transporter mediates the passage of small zwitterionic amino acids across the cell membrane and regulates the cell homeostasis and its volume. We have examined the expression of SNAT2 mRNA and protein during the development of the rat cerebral cortex, from gestation through the postnatal stages to adulthood. Our data reveal that SNAT2 mRNA and protein expression is higher during embryogenesis, while it subsequently diminishes during postnatal development. Moreover, during embryonic period SNAT2 colocalizes with the radial glial cells marker GLAST, while in postnatal period it is mainly detected in neuronal dendrites. These findings suggest a relevant role for amino acid transport through SNAT2 in the developing embryonic brain.


Subject(s)
Amino Acid Transport Systems/metabolism , Cerebral Cortex/embryology , Cerebral Cortex/growth & development , Cerebral Cortex/metabolism , Amino Acid Transport System A/metabolism , Amino Acid Transport Systems/genetics , Animals , Cerebral Cortex/anatomy & histology , Excitatory Amino Acid Transporter 1/metabolism , Female , Gene Expression Regulation, Developmental , Pregnancy , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Sodium/metabolism
10.
Neurosci Lett ; 486(3): 171-3, 2010 Dec 17.
Article in English | MEDLINE | ID: mdl-20863873

ABSTRACT

5-Hydroxytryptamine (5-HT) is involved in a variety of different physiological processes and behaviors through the activation of equally diverse receptors subtypes. In this work we studied the changes on the expression of 5-HT(5A) receptors in rat hippocampus induced by leptin, an adipocyte-derived hormone that has been reported to participate in the modulation of food intake and in adult hippocampal neurogenesis. To study the effect of leptin on the 5-HT(5A) receptor gene expression a qRT-PCR was used and the distribution of those receptors in the hippocampus was visualized by immunohistochemistry. Rats were separated in four groups: control (untreated rats), leptin-treated, serotonin-treated and leptin+serotonin treated. The results showed that even though the 5-HT(5A) gene expression did not change in the hippocampus of any of the treated groups, in the rats treated with leptin and serotonin, the specific immunostaining for the 5-HT(5A) serotonin receptor decreased significantly in the dentate gyrus.


Subject(s)
Down-Regulation/physiology , Hippocampus/metabolism , Leptin/physiology , Receptors, Serotonin/metabolism , Serotonin/physiology , Animals , Dentate Gyrus/metabolism , Gene Expression Regulation/physiology , Injections, Intraperitoneal , Leptin/administration & dosage , Male , Neurogenesis/genetics , Neurogenesis/physiology , Rats , Rats, Sprague-Dawley , Receptors, Serotonin/deficiency , Receptors, Serotonin/genetics , Serotonin/administration & dosage , Synaptic Transmission/physiology
11.
J Agric Food Chem ; 56(18): 8737-44, 2008 Sep 24.
Article in English | MEDLINE | ID: mdl-18754663

ABSTRACT

Common beans ( Phaseolus vulgaris L.) contain a high proportion of undigested carbohydrates (NDC) that can be fermented in the large intestine to produce short-chain fatty acids (SCFA) such as acetate, propionate, and butyrate. The objective of the present study was to evaluate the composition and chemopreventive effect of a polysaccharide extract (PE) from cooked common beans ( P. vulgaris L) cv. Negro 8025 on azoxymethane (AOM) induced colon cancer in rats. The PE induced SCFA production with the highest butyrate concentrated in the cecum zone: 6.7 +/- 0.06 mmol/g of sample for PE treatment and 5.29 +/- 0.24 mmol/g of sample for PE + AOM treatment. The number of aberrant crypt foci (ACF) and the transcriptional expression of bax and caspase-3 were increased, and rb expression was decreased. The data suggest that PE decreased ACF and had an influence on the expression of genes involved in colon cancer for the action of butyrate concentration.


Subject(s)
Azoxymethane , Colonic Neoplasms/prevention & control , Phaseolus/chemistry , Polysaccharides/administration & dosage , Polysaccharides/chemistry , Animals , Butyrates/analysis , Cecum/chemistry , Colonic Neoplasms/chemically induced , Colonic Neoplasms/pathology , Gene Expression , Hot Temperature , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Rats , Rats, Sprague-Dawley
12.
Int J Dev Neurosci ; 26(3-4): 319-22, 2008.
Article in English | MEDLINE | ID: mdl-18339511

ABSTRACT

The distribution of the glycine receptor subunits alpha1-3 and beta in the developing rat cerebellum was studied from postnatal day 1 to adulthood by means of quantitative RT-PCR and immunohistochemistry. qRT-PCR of postnatal cerebella indicated the presence of mRNA for each subunit, with a relative expression of alpha2>alpha3>alpha1>beta. The immunohistochemistry indicated a strong alpha2 signal in the Purkinje cells, internal and external granular layers. The alpha1-3 subunits had weak signals in the Purkinje cells and molecular layer. The alpha1 subunit was expressed at a low level and was also found in the white matter. The function of these receptors in neuronal and glial plasma membranes in early postnatal development remains to be determined.


Subject(s)
Cell Membrane/metabolism , Cerebellum/growth & development , Cerebellum/metabolism , Gene Expression Regulation, Developmental/physiology , Glycine/metabolism , Receptors, Glycine/genetics , Animals , Animals, Newborn , Immunohistochemistry , Protein Subunits/genetics , Protein Subunits/metabolism , RNA, Messenger/analysis , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, Glycine/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Subcellular Fractions
13.
Neurosci Lett ; 432(1): 1-6, 2008 Feb 13.
Article in English | MEDLINE | ID: mdl-18201822

ABSTRACT

In the present study, we provide evidence for the expression of all three GABA(C) receptor rho subunits through development of the rat cerebellum. Injection of cerebellum mRNA into frog oocytes gave rise to the expression of both GABA(A) and GABA(C) receptors. qRT-PCR of RNA isolated from postnatal developing cerebella showed that the expression of each rho subunit is relatively low, with a relative comparative expression of rho3>rho1>rho2. In situ hybridization and immunohistochemistry revealed a limited distribution of GABA(C) receptors in the Purkinje and Golgi neurons whereas electron microscopy detected the rho1 and rho2 subunits in the soma and dendritic tree of the Purkinje cells. The expression of GABA(C) receptors in the cerebellum adds a new dimension to the regulation of GABAergic neurotransmission and suggests further experiments to determine their functional consequences.


Subject(s)
Cerebellum/growth & development , Cerebellum/physiology , Receptors, GABA/genetics , Animals , Anura , Gene Expression Regulation, Developmental , Male , Microscopy, Immunoelectron , Oocytes/physiology , Purkinje Cells/physiology , Purkinje Cells/ultrastructure , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, GABA/metabolism , Receptors, GABA-A , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...